To study the effect of Mustadi Ghanavati and Bolabaddha Rasa in Excessive Menstural Bleeding.

Phase 1/2

Not yet recruiting

Conditions: Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,

Registration Number: CTRI/2023/08/057120

Lead Sponsor: Parul Institute Of Ayurved

Brief Summary: The process of cyclic menstruation is natural phenomenon. Regular cyclic menstruation results from the relationship between the endometrium and its regulating factors. Menstruation denotes the healthy state of female reproductive system but if the cycle turns to be abnormal with excessive and prolonged bleeding, associated with pain or during intermenstrua lperiod, it is suggestive of some underlying pathology. In modern science asrigdara can be closely co-related with DUB. Dysfunctional uterine bleeding is best defined as abnormal uterine bleeding without any clinically detectable organic, systemic and iatrogenic cause (pelvic pathology i.e tumors, inflammation or pregnancy is excluded). The current line of treatment include medical and surgical methods, plays insignificant role besides the adverse effects. Hormones play a major role in the

management of DUB (Asrigdara) but their use for longer period is proved to be dangerous and sometimes induce carcinogenic effect on the genital tract. In view of the problems of the current therapies, need is felt to revalidate certain ayurvedic formulations for the management of asrigdara without adverse effects.

Aim

To compare the effect of *Mustadi Ghanavati* and *Bolbaddha Rasa* in the management of *Asrigdara* .

Objectives

To study the Aetiopathogenesis of *Asrigdara* with special reference to dysfunctional uterine bleeding.

To evaluate the efficacy of *Mustadi Ghanavati**.*

To compare the efficacy of *Mustadi Ghanavati* and *Bolbaddha Rasa* in *Asrigdara.*

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 60

Inclusion Criteria

1.Patients who were willing for the hospital trial.
2.Patients fulfilling the diagnostic criteria.
3.Patients diagnosed as DUB (without organic pathology) 4.Both married and unmarried women.

Exclusion Criteria

1.Patients not willing for trial.
2.Patients with systemic disorders interfering with the present study like HTN, DM.
3.Patients with IUCD and patients taking OCPs. 4.Patients with uterine and pelvic pathology (fibroid, adenomyosis ) ,Benign and malignant growth in uterus.
5.Patient with Hb < 7 gm% 6.Threatened, spontaneous or incomplete abortion,Endometrial and endocervical polyp..

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Beneficial for irregular prolonged & heavy menses	2 Months with 1 Month followup.

Secondary Outcome Measures

Name	Time	Method
Also reduce symptoms like Angamarda, daurbalya, bhrama, aruchi, daha, trusha.	2 Months with 1 Month followup

Trial Locations

Locations (1): Parul Institute of Ayurved
🇮🇳
Vadodara, GUJARAT, India
Parul Institute of Ayurved
🇮🇳Vadodara, GUJARAT, India
Dr Jeenal Patel
Principal investigator
8238542625
jeenalpatel7297@gmail.com